Company intelligence / Profile preview

Aquestive Therapeutics

Warren, New Jersey, United Statesaquestive.com ↗
Ownership
Public · AQST
Employees
~175
Development stage
Commercial
01

Overview

Aquestive has completed pivotal Phase III studies for Anaphylm™ (epinephrine sublingual film) showing comparable or faster absorption than leading autoinjectors. NDA submission to FDA expected Q1 2025; pediatric data in line with expectations. Five products are already commercialized through licensees, including Sympazan® oral film for Lennox-Gastaut Syndrome[3][7][10].

Therapeutic areas
DermatologyImmunologyNeurology
Modalities
Oral film drug delivery (PharmFilm® technology)Topical gel formulations
Industry
Biotech
02

Drug pipeline

8 assets

libervant

Approved

7 more assets in the full pipeline.

Request access →
03

Partnerships

Collaborates with pharmaceutical companies to bring new molecules to market using PharmFilm®, but specific partners not listed in current results[4][6].Licensees market its products globally.
04

Financials

Market cap
$653.7M
Total revenue
$13.8M
Enterprise value
$614.2M

Beyond the preview

Go deeper on Aquestive Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aquestive Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call